Ex parte ASJES - Page 3



          Appeal No. 1997-1266                                                         
          Application 08/078,791                                                       



          TuXuan (PCT/EP)          WO 91/15036          Oct.  3, 1991                  
                                                                                      
               Claims 1 through 3, 5 through 9, 11, 12 and 15 through 24               
          stand rejected under 35 U.S.C. § 103 as being unpatentable                   
          over TuXuan in view of DeLanty.                                              
               Rather than reiterate the arguments of Appellant and the                
          Examiner, reference is made to the brief and answer for the                  
          respective details thereof.                                                  


                                       OPINION                                         
               After a careful review of the evidence before us, we                    
          agree with the Examiner that claims 1 through 3, 7, 8, 9, 12,                
          16, 17 and 22 are properly rejected under 35 U.S.C. § 103.                   
          Thus, we will sustain the rejection of these claims, but we                  
          will reverse the rejection of claims 5, 6, 11, 15, 18 through                
          21, 23 and 24 for the reasons set forth infra.                               
               At the outset, we note that Appellant has indicated on                  
          page 7 of the brief that claims 1 through 3, 8, 9, 12, 16, 17                
          and 22  stand together, which we will indicate as group I and                
          select claim 1 as the representative claim.  Also, Appellant                 
          has indicated that claims 5, 6, 11, 15, 18 through 21 and 23                 
          stand together, which we will indicate as group II and select                

                                           3                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007